- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04775004
Comparing Meniscal Repair Biologic Augmentation: Marrow Venting Procedure Versus PRP (MVP Trial)
There are no current or past RCT comparing biologic augments for meniscal repair. There is good data supporting both the use of BMVP of the intercondylar notch and intra-articular PRP injections for augmentation of meniscal repair. However, the effectiveness of these augmentation methods with respect to each other has never been investigated. The knowledge gained will allow us to potentially influence and adapt protocols to treat this particular patient population. Additionally, resources available at our institution provide a supportive framework with which to maintain contact with patients after hospital discharge. These key factors will allow us to perform a robust analysis of this population, to include outcomes measures of function as well as meniscal repair failure and reoperation rate.
The proposed interventional aim to compare meniscal repair augmentation methods is novel, as the direct comparison of these outcome measures has not been previously described. Because of the known benefit of biologic augmentation of meniscal repair, the investigators hypothesize that the repair failure rate for both cohorts will be lower than the reported repair failure rate for isolated tears without biologic augmentation; the investigators also hypothesize that BMVP of the intercondylar notch will clinically be significantly better than intra-articular PRP injection. The basis behind this hypothesis is in vivo evidence as well as a small RCT supporting the use of BMVP as augmentation for meniscal repair procedures.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32611
- Recruiting
- University of Florida
-
Contact:
- Marissa Pazik, MS
- Email: pazikmn@ortho.ufl.edu
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- Recruiting
- University of Chicago Medicine
-
Contact:
- Justin Bell
- Phone Number: 773-834-0822
-
Principal Investigator:
- Aravind Athiviraham, MD
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Recruiting
- Wake Forest University Health Sciences
-
Contact:
- Erica Hartzell, MS
- Email: ehartzel@wakehealth.edu
-
Contact:
- Nina Cruz-Diaz
- Email: nmcruzdi@wakehealth.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
- Age 16 or older
- Medial, lateral, vertical longitudinal, oblique, or radial meniscal tear
- Complex tears may be included at the discretion of the site investigator if patient has one of tear patterns listed in inclusion criteria 2 as the most predominant finding
No other concomitant procedure unless one of the following:
- Chondroplasty
- Synovectomy
- Loose body removal
- "Contralateral" menisectomy (i.e. medial meniscus repair with a lateral menisectomy or lateral meniscus repair with a medial menisectomy) would be permitted for inclusion
- Any other procedure that does not include drilling, requires prior approval of the study sponsor for each procedure
Exclusion Criteria
- Patients requiring cartilage restorative or repair procedures (i.e. OCD fixation, micro-fracture repair, or others)
- Patients with meniscus root tears
- Patients undergoing repair for horizontal cleavage tears
- Kellgren-Lawrence scale 3>
- Patients undergoing lateral release
- Ipsilateral chondral lesion with Outerbridge classification of 3-4
- Use of prednisone or other steroids, any immunosuppressant, or chemotherapy 1-week before surgery or expected use within six weeks after surgery
- Cortisone use within the six weeks prior to surgery
- Utilizing worker's compensation at the time of screening
- Any previous ligament surgery on the index limb. Any previous meniscal surgery on the index meniscus.
- Concomitant ligamentous insufficiency
- Inflammatory rheumatic disease or other rheumatic disease
- Immune compromised patients (hepatitis, HIV, etc.)
- Any nicotine based products within the three months prior to surgery (including cigarettes, cigars, vaping, nicotaine patch, etc)
- History of distal femur, proximal tibia, or patellar fracture that was treated operatively
- Non English-speaking patients
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Bone marrow venting procedure (BMVP)
Subjects randomized in the OR to undergo BMVP surgical augmentation
|
The BMVP involves creating small holes in a non-weight bearing area of the bone that does not have any important structures; the holes act as channels, which allow for flow of the participants own biologic products and stem cells from within the bone marrow.
|
Active Comparator: Platelet rich plasma (PRP)
Subjects randomized in the OR to undergo PRP surgical augmentation
|
The PRP group will have 40cc to 60cc (about 3 tablespoons) of blood drawn at the time of surgery.
The blood sample will then be prepared in a centrifuge machine to collect a component of the blood called platelet rich plasma.
Once appropriate concentrations of the PRP are confirmed, the PRP will be injected into the subject's knee prior to wound closure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Promis Physical function CAT lower extremity score
Time Frame: 1-year after meniscus tear operation.
|
Adaptive questionnaire that takes five minutes or less to complete and helps record how subject injury and recovery from surgery is affecting their normal life.
|
1-year after meniscus tear operation.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Re-tear of repair meniscus
Time Frame: 1-year after meniscus tear operation.
|
Clinically reported (symptomatic) and MRI confirmed via observation of fluid filled tear in the repaired tissue
|
1-year after meniscus tear operation.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Aravind Athiviraham, MD, University of Chicago
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB20-1394
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Meniscal Tear
-
Smith & Nephew, Inc.CompletedMeniscal Tear | Meniscus TearUnited States
-
Federal University of Health Science of Porto AlegreCompleted
-
Karolinska InstitutetRecruiting
-
Christian CandrianRecruitingMeniscal TearSwitzerland
-
Fowler Kennedy Sport Medicine ClinicSmith & Nephew, Inc.CompletedMeniscal TearCanada
-
Oslo University HospitalUniversity of Southern DenmarkUnknownDegenerative Meniscal TearNorway
-
Onze Lieve Vrouwe GasthuisZonMw: The Netherlands Organisation for Health Research and Development; Stichting...CompletedMeniscal TearNetherlands
-
Omeros CorporationCompleted
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Kaplan Medical CenterProCore Ltd.Unknown
Clinical Trials on Bone marrow venting procedure (BMVP)
-
Christian CandrianRecruitingMeniscal TearSwitzerland
-
Zimmer BiometTerminatedPeripheral Arterial Disease | Peripheral Vascular Disease | Critical Limb IschemiaUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH)Enrolling by invitationLymphoproliferative Disorders | Myelodysplastic Syndromes | Myeloproliferative Disorders | Acute LeukemiaUnited States
-
Johns Hopkins UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsNot yet recruitingOsteonecrosis of the Femoral Head | Avascular Necrosis of the Femoral HeadUnited States
-
Shane A. ShapiroRecruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid System NeoplasmUnited States
-
Johns Hopkins UniversityON FoundationNot yet recruitingRotator Cuff TearsUnited States
-
University of Wisconsin, MadisonNational Heart, Lung, and Blood Institute (NHLBI)CompletedGraft Versus Host Disease (GVHD) | Acute Myocardial Infarction (AMI)United States
-
Emory UniversityCompleted
-
Zimmer BiometNo longer availablePeripheral Arterial Disease | Peripheral Vascular Diseases | Critical Limb IschemiaUnited States